Table 2. Various parameters in patients with COVID-19 vaccine-induced myocarditis.
EKG: electrocardiogram; CRP: C-reactive protein; BNP: brain natriuretic peptide
| Parameters | Values (±standard deviation SD) |
| Age | 29.125 (±14.39) years |
| Gender | 36 males (90%); 4 females (10%) |
| Vitals | |
| Systolic blood pressure | 119. 72 (±22.36) mmHg |
| Diastolic blood Pressure | 71.44 (±10.65) mmHg |
| Heart rate | 93.17 (±21.41) beats per minute |
| SpO2 | 94% (±7.9%) |
| Type of vaccination | Pfizer - 26 (65%); Moderna - 12 (30%); Janssen (J&J) - 2 (5%) |
| After which dose of vaccine they developed symptoms | 1st dose: 3 cases (7.50%) 2nd dose: 32 cases (80%) Unknown: 5 cases (13%) |
| How many days after vaccination patient hospitalized? | 5.09 days (±14.04 days) |
| EKG changes | Number of cases (percentage) |
| ST-elevation | 25 (62.50%) |
| Normal | 8 (20%) |
| T-wave changes | 5 (13%) |
| PR depression | 2 (5%) |
| Laboratory values | Values (±standard deviation) |
| Peak troponin I level | 162.275 ng/mL (±754.804 ng/mL) |
| CRP | 26.43 mg/L (±31.98 mg/L) |
| BNP | 51.31 pg/ml (±25.64 pg/ml) |